Publication: Editorial: Mechanisms and New Targets for the Treatment of Chronic Pain.
dc.contributor.author | Nieto, Francisco Rafael | |
dc.contributor.author | Vuckovic, Sonja Maksim | |
dc.contributor.author | Prostran, Milica S | |
dc.date.accessioned | 2023-02-09T09:45:29Z | |
dc.date.available | 2023-02-09T09:45:29Z | |
dc.date.issued | 2020-09-16 | |
dc.description.abstract | Nociceptive pain has a physiological protective role in preventing tissue injury. However, pain can become chronic due to a multitude of pathophysiological states, such as: inflammation, nerve injury, tumors, infections, autoimmune diseases, and vascular and metabolic disorders. These pathological states can trigger alterations of the pain pathways that can lead to painful hypersensitivity, and in such circumstances, pain loses its protective role and instead, becomes chronic, pathologic, and it can be extremely debilitating for people who suffer from it (Basbaum et al., 2009). Chronic pain has recently been defined as pain that persists or recurs for more than 3 months (Treede et al., 2019) | |
dc.description.version | Si | |
dc.identifier.citation | Nieto FR, Vuckovic SM, Prostran MS. Editorial: Mechanisms and New Targets for the Treatment of Chronic Pain. Front Pharmacol. 2020 Sep 29;11:600037. doi: 10.3389/fphar.2020.600037. | |
dc.identifier.doi | 10.3389/fphar.2020.600037 | |
dc.identifier.issn | 1663-9812 | |
dc.identifier.pmc | PMC7550778 | |
dc.identifier.pmid | 33117184 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550778/pdf | |
dc.identifier.unpaywallURL | https://www.frontiersin.org/articles/10.3389/fphar.2020.600037/pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/16497 | |
dc.journal.title | Frontiers in pharmacology | |
dc.journal.titleabbreviation | Front Pharmacol | |
dc.language.iso | en | |
dc.organization | Hospital Universitario San Cecilio | |
dc.organization | Hospital Universitario Virgen de las Nieves | |
dc.organization | Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA) | |
dc.page.number | 4 | |
dc.publisher | Frontiers Research Foundation | |
dc.pubmedtype | Editorial | |
dc.relation.publisherversion | https://doi.org/10.3389/fphar.2020.600037 | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | analgesics | |
dc.subject | cancer-related pain | |
dc.subject | chronic pain | |
dc.subject | musculoskeletal pain | |
dc.subject | neuropathic pain | |
dc.subject | pain | |
dc.subject | persistent pain | |
dc.subject | visceral pain | |
dc.subject.decs | Dolor crónico | |
dc.subject.decs | Dolor nociceptivo | |
dc.subject.decs | Enfermedades metabólicas | |
dc.subject.decs | Enfermedades del sistema nervioso periférico | |
dc.subject.decs | Inflamación | |
dc.subject.decs | Neoplasias | |
dc.subject.mesh | Chronic Pain | |
dc.subject.mesh | Peripheral Nervous System Diseases | |
dc.subject.mesh | Nociceptive Pain | |
dc.subject.mesh | Metabolic Diseases | |
dc.subject.mesh | Neoplasms | |
dc.subject.mesh | Inflammation | |
dc.title | Editorial: Mechanisms and New Targets for the Treatment of Chronic Pain. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 11 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1